Grants and Contracts per year
Personal profile
Education/Academic qualification
Post Doctoral Fellow, Stanford University
2019
Post Doctoral Fellow, New York Medical College
2018
Residency, New York Medical College
2015
Bachelor of Medicine, Bachelor of Surgery, Other Institution
2011
-
23-NHL-29-DO: MK2140-003, A Phase 2/3 Multicenter, Open-label, Randomized, Active-Control Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (waveLINE-003)
Merck Sharp & Dohme Corporation
6/26/23 → 6/26/25
Project: Research project
-
A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator s Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Iragavarapu, C. & Hildebrandt, G.
12/15/21 → 7/31/24
Project: Research project
-
Expanded Access Protocol (EAP) For Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming For Commercial Release
4/6/21 → 3/15/24
Project: Research project